Stockholm, June 11, 2014 — NASDAQ OMX (NASDAQ:NDAQ) announced that Episurf Medical AB (short name: EPIS B), a Small Cap company within the Health Care sector, has started trading of its shares on the main market of NASDAQ OMX Stockholm. Episurf Medical has since 2011 been listed on NASDAQ OMX First North in Stockholm and is, including switches, the twelfth company to list at NASDAQ OMX’s Nordic main markets in 2014 (NASDAQ OMX Stockholm; Helsinki; Copenhagen; and Iceland).
Episurf Medical is a Swedish medical device company, the first in the world to offer patient-specific implants and surgical instruments for the treatment of painful joint injuries. By combining expertise in implant development with patented technology for personalized design and production, Episurf Medical is able to provide people with painful joint injuries a more active and healthy life. For more information, visit www.episurf.com.
“We have a strong technology core and a vision of setting a new standard in inidividually customized orthopaeidics,” said Nina Bake, CEO of Episurf Medical. “Entering the main market gives us a solid foundation for our future growth enabling the company to continue our journey towards becoming a global industry leader.”
To view a CEO interview from the listing ceremony click here.
About NASDAQ OMX Group
NASDAQ OMX (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents. Through its diverse portfolio of solutions, NASDAQ OMX enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today’s global capital markets. As the creator of the world’s first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and approximately 1 in 10 of the world's securities transactions. NASDAQ OMX is home to more than 3,400 listed companies with a market value of over $8.5 trillion and more than 10,000 corporate clients. To learn more, visit www.nasdaqomx.com.
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about futures products to be traded on NFX and NASDAQ OMX's other products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond NASDAQ OMX's control. These factors include, but are not limited to factors detailed in NASDAQ OMX's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.
|
Media Relations Contact: Christina Malmberg Hägerstrand +46 (0) 8 405 65 83 Christina.Hagerstrand@nasdaqomx.com |
